During the past decade, Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling" in a lesser frequency.

Most popular intervention types in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "CHOP" (1 trials), "Placebo" (1 trials), "Rituximab" (1 trials) and "docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".